AG
QTTB icon

Advisor Group’s Q32 Bio QTTB Stock Holding History

Advisor Group’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$24K Hold
64
– – ﹤0.01% 3870
2019
Q3 		$21K Hold
64
– – ﹤0.01% 3942
2019
Q2 		$23K Buy
64
+8
+14% +$3.14K ﹤0.01% 3906
2019
Q1 		$28K Hold
56
– – ﹤0.01% 3791
2018
Q4 		$22K Buy
+56
New +$21.2K ﹤0.01% 3752

Other funds holding QTTB

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Advisor Group's QTTB Position: Q4 2019 in Review

Advisor Group held its Q32 Bio (QTTB) position steady in Q4 2019 at 64 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #3870.

Advisor Group first reported a position in QTTB in Q4 2018 and has held it in 5 quarters since. The position peaked at $28K in Q1 2019. 86 funds tracked by Wall St. Rank hold QTTB as of Q4 2019.

  • Advisor Group held 64 shares of Q32 Bio worth $24K as of Q4 2019.
  • Advisor Group left its Q32 Bio share count unchanged in Q4 2019.
  • Q32 Bio made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3870 holding.
  • Advisor Group first reported a position in Q32 Bio in Q4 2018 and has held it in 5 quarters since.
  • Advisor Group's Q32 Bio position peaked at $28K in Q1 2019.
  • 86 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.